NDC 0591-5513

Carisoprodol

Carisoprodol

Carisoprodol is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Carisoprodol.

Product ID0591-5513_47645d9b-8a05-4adf-979d-78791eac4da9
NDC0591-5513
Product TypeHuman Prescription Drug
Proprietary NameCarisoprodol
Generic NameCarisoprodol
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1987-11-01
Marketing CategoryANDA / ANDA
Application NumberANDA087499
Labeler NameActavis Pharma, Inc.
Substance NameCARISOPRODOL
Active Ingredient Strength350 mg/1
Pharm ClassesCentrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
DEA ScheduleCIV
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0591-5513-01

100 TABLET in 1 BOTTLE (0591-5513-01)
Marketing Start Date1987-11-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0591-5513-05 [00591551305]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1987-11-01

NDC 0591-5513-01 [00591551301]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1987-11-01

NDC 0591-5513-00 [00591551300]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-06-20
Marketing End Date2012-06-12

NDC 0591-5513-10 [00591551310]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1987-11-01

Drug Details

Active Ingredients

IngredientStrength
CARISOPRODOL350 mg/1

OpenFDA Data

SPL SET ID:ad627894-4d1e-4dae-8421-9aa1ce9a0208
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197446

    • Pharmacological Class

    • Centrally-mediated Muscle Relaxation [PE]
    • Muscle Relaxant [EPC]

    NDC Crossover Matching brand name "Carisoprodol" or generic name "Carisoprodol"

    NDCBrand NameGeneric Name
    0143-1176CarisoprodolCarisoprodol
    0143-9749CarisoprodolCarisoprodol
    0591-5513CarisoprodolCarisoprodol
    0603-2582CarisoprodolCarisoprodol
    10544-033CarisoprodolCarisoprodol
    10544-088CARISOPRODOLCARISOPRODOL
    10544-132CarisoprodolCarisoprodol
    12634-437CarisoprodolCarisoprodol
    16571-780carisoprodolcarisoprodol
    16571-781carisoprodolcarisoprodol
    16714-510CarisoprodolCarisoprodol
    29033-207CarisoprodolCarisoprodol
    29033-214CarisoprodolCarisoprodol
    33261-387CarisoprodolCarisoprodol
    33358-064CARISOPRODOLCARISOPRODOL
    35356-721CarisoprodolCarisoprodol
    42254-068CarisoprodolCarisoprodol
    42543-434CARISOPRODOLCARISOPRODOL
    42543-700CARISOPRODOLCARISOPRODOL
    43063-302CarisoprodolCarisoprodol
    43063-824CarisoprodolCarisoprodol
    43353-102CARISOPRODOLCARISOPRODOL
    68071-2188CarisoprodolCarisoprodol
    68071-4263CarisoprodolCarisoprodol
    68071-4112CarisoprodolCarisoprodol
    68071-4610CARISOPRODOLCARISOPRODOL
    68387-600CarisoprodolCarisoprodol
    68788-6866CarisoprodolCarisoprodol
    68788-2582CarisoprodolCarisoprodol
    68788-9976CARISOPRODOLCARISOPRODOL
    70518-0704CarisoprodolCarisoprodol
    70518-1092CarisoprodolCarisoprodol
    70518-1401CarisoprodolCarisoprodol
    71335-0131CarisoprodolCarisoprodol
    71205-241CARISOPRODOLCARISOPRODOL
    71335-0407CarisoprodolCarisoprodol
    71335-0516CARISOPRODOLCARISOPRODOL
    71335-0693CARISOPRODOLCARISOPRODOL
    71610-097CARISOPRODOLCARISOPRODOL
    75921-513CARISOPRODOLCARISOPRODOL
    76333-135CarisoprodolCarisoprodol
    50090-0281CarisoprodolCarisoprodol
    49999-064CarisoprodolCarisoprodol
    50090-0280CarisoprodolCarisoprodol
    50090-2530CarisoprodolCarisoprodol
    50090-3232CarisoprodolCarisoprodol
    50090-3048CARISOPRODOLCARISOPRODOL
    50090-3211CarisoprodolCarisoprodol
    50090-2771CarisoprodolCarisoprodol
    50228-109CARISOPRODOLCARISOPRODOL
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.